• image description

    Helion Energy wins energy generation category at Cleantech Open

    By Clare LaFond Helion Energy, developer of a revolutionary fusion technology aimed at addressing the world’s growing clean energy demands, was one of five national finalists in the CleanTech Open held Nov. 20-21 in San Jose, Calif. Formed by scientists and engineers, many coming from the UW, Helion won in the Energy Generation category and was one of only two Pacific Northwest small businesses toView More

  • image description

    Innovator Recognition 2013 celebrates entrepreneurial spirit

    By Clare LaFond Watch the C4C Innovator Recognition Video. University of Washington President Michael Young joined more than 200 guests from across campus Dec. 10 for C4C’s second annual Innovator Recognition event. The event celebrated UW’s entrepreneurial researchers, faculty, and the many talent philanthropists working with them to propel ideas out of the lab and into the marketplace. Sixteen researchers competed in C4C’s Innovator ShowcaseView More

  • UW spin out Qazzow receives seed investment from W Fund

    By Clare LaFond UW start-up Qazzow has secured $500,000 in seed investment from the W Fund, an early stage venture fund focused on leveraging Washington’s research strength to launch new businesses. See related story in GeekWire. Qazzow, a spin-out from the UW’s Information School, has created a breakthrough service that significantly improves the consumer experience with websites and web applications. The company is currently pilotingView More

  • image description

    Nanopore sequencing technology lands licensing deal

    By Clare LaFond Researchers led by University of Washington physicist Jens Gundlach have developed a nanopore sequencing technology capable of reading the sequence of a single DNA molecule, technology that has led to a patent-licensing deal between UW and Illumina Inc. See related story in Puget Sound Business Journal. In this system, the DNA is pulled through a nanopore while an ion current through theView More

  • image description

    C4C New Ventures Facility recognized among world’s top business incubators

    Story by Clare LaFond Photos by Conrado Tapado The C4C New Ventures Facility (NVF) at UW has been named in a ranking of the top university business incubators in the world by the 2013 University Business Incubators (UBI) Global Index, a new research initiative led by a study group based in Stockholm, Sweden. The UW’s NVF programs were among the top 10 globally and theView More

  • image description

    UW spin-out MarqMetrix provides real-time product quality improvement

    By Clare LaFond What if you could instantly ensure the quality of products across multiple industries – from farm-raised salmon and popular brand-name cookies to pharmaceutical drugs and petrochemicals used in plastics – simply by touching the tip of a “smart” light-sensing probe to the product at hand? That’s exactly what UW spin-out MarqMetrix™ has developed – and recently licensed through C4C — in theView More

  • image description

    Seattle’s PhaseRx transforms its business plan to create new therapeutic options to treat liver cancer

    By Eran Moore Rea C4C Impact Investigations ask: where do UW start-ups go when they leave UW? Our start-ups create economic, social, and environmental impact in Washington state. Let’s check back with some of our early start-ups—now established companies—and investigate their influence and effect. In early 2008, PhaseRx raised $19 million in venture capital funding. “This was right before the window closed,” CEO Robert OverellView More

  • image description

    GenetikSignal signs exclusive licensing agreement with UW for anti-aging biotechnology

    What if you could not only slow down the aging process, but delay the onset and progression of age-related disease at the same time? That’s the idea behind the research of Matt Kaeberlein, University of Washington associate professor of pathology and a prominent scientist in the field of aging research. Now, GenetikSignal, Inc., a biotech startup based in Maryland, has entered into an exclusive licensingView More

  • image description

    “Stealth device” could transform hidden heart condition monitoring

    By Sandy Marvinney A University of Washington spinoff company, Cardiac Insight, has set its sights on improving screening for one of the most common forms of irregular heartbeat — atrial fibrillation (a-fib). This condition affects about 2.2 million people in the U.S. and causes an estimated 50,000 to 70,000 strokes a year. A-fib is a challenge to detect during routine physicals because patients may notView More

  • image description

    Executive Academic Part 1: To CEO or not to CEO?

    By Eran Moore Rea Finally, your research works! You’ve churned through enough tin foil and recycled code to create something you could develop as a product. Your discoveries could change the world. What’s next? How do you present your product to investors? What exactly is your product? How do you run a company? Do you want to run a company? These are not questions inventorsView More